Lymphoma
Lymphoma is a broad term for lymphatic cancer, cancer that start in the lymphatic system and that can develop anywhere lymphocytes, the cells of the lymphatic system, travel. Because of this travelling and the fact that lymphatic tissue is present in many parts of the body, lymphoma can start almost anywhere in the human body. There are two main types of lymphoma: Hodgkin lymphoma (HL) or Hodgkin disease and non-Hodgkin lymphoma (NHL).
NHL Is the major type of lymphoma with more than 85 % of diagnosis as compared to Hodgkin lymphoma. It differs from Hodgkin lymphoma by: the way cells behave and their look under a microscope, the presence of Reed-Sternberg cells in Hodgkin lymphoma and how the two types of lymphoma are treated.
Click on the following links for more information on Hodgkin Lymphoma (HL) or Hodgkin disease and Non-Hodgkin Lymphoma (NHL).
Research projects focused on this topic
- New prognostic markers in mantle cell lymphoma
- Characterizing cell-based models for non-Hodgkin's lymphoma
- Functional relationship between EGR-1 and MMP-9 during lymphoma progression
- Identification of novel biomarker in multiple myeloma therapy resistance
- Regulation of the mutagenic capacity of the antibody diversification enzyme AID by Hsp90
- Regulatory T cell therapy for graft versus host disease
- Role of the transcription factor Gfi1 and the Gfi136N variant in Acute myeloid leukemia (AML)
